Supplementation with high-content docosahexaenoic acid triglyceride in attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial

References

• Matthews M, Nigg JT, Fair DA. Attention deficit hyperactivity disorder. Curr Top Behav Neurosci. 2014;16:235–266. doi:10.1007/7854_2013_24924214656
   PubMedGoogle Scholar
• Rodríguez C, Areces D, García T, Cueli M, González-Castro P. Comparison between two continuous performance tests for identifying ADHD: traditional vs. virtual reality. Int J Clin Health Psychol. 2018;18(3):254–263. doi:10.1016/j.ijchp.2018.06.00330487931
   PubMed Web of Science ®Google Scholar
• Catalá-López F, Hutton B, Núñez-Beltrán A, et al. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: protocol for a systematic review and network meta-analysis of randomized controlled trials. Syst Rev. 2015;4(1):19. doi:10.1186/s13643-015-0005-725875125
   PubMedGoogle Scholar
• García T, Rodríguez C, Rodríguez J, Fernández-Suárez A, Richarte V, Ramos-Quiroga JA. Psychosocial profiles of adults with ADHD: a comparative study of prison and outpatient psychiatric samples. Eur J Psychol Appl L. 2019;11:41–49. doi:10.5093/ejpalc2018a14
   Web of Science ®Google Scholar
• Hodgson K, Hutchinson AD, Denson L. Nonpharmacological treatments for ADHD: a meta-analytic review. J Atten Disord. 2014;18(4):275–282. doi:10.1177/108705471244473222647288
   PubMed Web of Science ®Google Scholar
• Sonuga-Barke EJ, Brandeis D, Cortese S, et al. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry. 2013;170(3):275–289. doi:10.1176/appi.ajp.2012.1207099123360949
   PubMed Web of Science ®Google Scholar
• Chang JPC, Su KP, Mondelli V, Pariante CM. Omega-3 polyunsaturated fatty acids in youths with attention deficit hyperactivity disorder: a systematic review and meta-analysis of clinical trials and biological studies. Neuropsychopharmacology. 2018;43(3):534–545. doi:10.1038/npp.2017.16028741625
   PubMed Web of Science ®Google Scholar
• Innis SM. Dietary omega 3 fatty acids and the developing brain. Brain Res. 2008;1237:35–43. doi:10.1016/j.brainres.2008.08.07818789910
   PubMed Web of Science ®Google Scholar
• McNamara RK, Carlson SE. Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot Essent Fatty Acids. 2006;75(4–5):329–349. doi:10.1016/j.plefa.2006.07.01016949263
   PubMed Web of Science ®Google Scholar
• Weiser MJ, Butt CM, Mohajeri H. Docosahexaenoic acid and cognition throughout the lifespan. Nutrients. 2016;8(2):99. doi:10.3390/nu802009926901223
   PubMed Web of Science ®Google Scholar
• Lauritzen L, Brambilla P, Mazzocchi A, Harslof LB, Ciappolino V, Agostoni C. DHA effects in brain development and function. Nutrients. 2016;8:pii E6. doi:10.3390/nu8010006
   Web of Science ®Google Scholar
• Chalon S. Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Fatty Acids. 2006;75(4–5):259–269. doi:10.1016/j.plefa.2006.07.005
   PubMed Web of Science ®Google Scholar
• Kitson AP, Metherel AH, Chen CT, et al. Effect of dietary docosahexaenoic acid (DHA) in phospholipids or triglycerides on brain DHA uptake and accretion. J Nutr Biochem. 2016;33:91–102. doi:10.1016/j.jnutbio.2016.02.00927135386
   PubMed Web of Science ®Google Scholar
• Cunnane SC, Chouinard-Watkins R, Castellano CA, Barberger-Gateau P. Docosahexaenoic acid homeostasis, brain aging and Alzheimer‘s disease: can we reconcile the evidence? Prostaglandins Leukot Essent Fatty Acids. 2013;88(1):61–70. doi:10.1016/j.plefa.2012.04.00622575581
   PubMed Web of Science ®Google Scholar
• Meyer BJ, Grenyer BF, Crowe T, Owen AJ, Grigonis-Deane EM, Howe PR. Improvement of major depression is associated with increased erythrocyte DHA. Lipids. 2013;48(9):863–868. doi:10.1007/s11745-013-3801-723733443
   PubMed Web of Science ®Google Scholar
• Gillies D, Sinn J, Lad SS, Leach MJ, Ross MJ. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Cochrane Database Syst Rev. 2012;11:7. doi:10.1002/14651858.CD007986.pub2
   Web of Science ®Google Scholar
• Hawkey E, Nigg JT. Omega-3 fatty acid and ADHD: blood level analysis and meta-analytic extension of supplementation trials. Clin Psychol Rev. 2014;34(6):496–505. doi:10.1016/j.cpr.2014.05.00525181335
   PubMed Web of Science ®Google Scholar
• Milte CM, Parletta N, Buckley JD, Coates AM, Young RM, Howe PR. Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/hyperactivity disorder: a randomized controlled trial. Nutrition. 2012;28(6):670–700. doi:10.1016/j.nut.2011.12.00922541055
   PubMed Web of Science ®Google Scholar
• Parletta N, Niyonsenga T, Duff J. Omega-3 and omega-6 polyunsaturated fatty acid levels and correlations with symptoms in children with attention deficit hyperactivity disorder, autistic spectrum disorder and typically developing controls. PLoS One. 2016;11:e0156432. doi:10.1371/journal.pone.015643227232999
   PubMed Web of Science ®Google Scholar
• Königs A, Kiliaan AJ. Critical appraisal of omega-3 fatty acids in attention-deficit/hyperactivity disorder treatment. Neuropsychiatr Dis Treat. 2016;12:1869–1882. doi:10.2147/NDT.S6865227555775
   PubMed Web of Science ®Google Scholar
• Ramalho R, Pereira AC, Vicente F, Pereira P. Docosahexaenoic acid supplementation for children with attention deficit hyperactivity disorder: a comprehensive review of the evidence. Clin Nutr ESPEN. 2018;25:1–7. doi:10.1016/j.clnesp.2018.03.12629779801
   PubMed Web of Science ®Google Scholar
• Cornu C, Mercier C, Ginhoux T, et al. A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with moderate ADHD symptoms. Eur J Adolesc Psychiatry. 2018;27(3):377–384. doi:10.1007/s00787-017-1058-z
   PubMed Web of Science ®Google Scholar
• Cooper RE, Tye C, Kuntsi J, Vassos E, Asherson P. Omega-3 polyunsaturated fatty acid supplementation and cognition: a systematic review and meta-analysis. J Psychopharmacol. 2015;29(7):753–763. doi:10.1177/026988111558795826040902
   PubMed Web of Science ®Google Scholar
• Cooper RE, Tye C, Kuntsi J, Vassos E, Asherson P. The effect of omega-3 polyunsaturated fatty acid supplementation on emotional dysregulation, oppositional behaviour and conduct problems in ADHD: a systematic review and meta-analysis. J Affect Disord. 2016;190:474–482. doi:10.1016/j.jad.2015.09.05326551407
   PubMed Web of Science ®Google Scholar
• Widenhorn-Müller K, Schwanda S, Scholz E, Spitzer M, Bode H. Effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit/hyperactivity disorder (ADHD): a randomized placebo-controlled intervention trial. Prostaglandins Leukot Essent Fatty Acids. 2014;91(1–2):49–60. doi:10.1016/j.plefa.2014.04.00424958525
   PubMed Web of Science ®Google Scholar
• Bloch MH, Qawasmi A. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 2011;50(10):991–1000. doi:10.1016/j.jaac.2011.06.00821961774
   PubMed Web of Science ®Google Scholar
• Bélanger SA, Vanasse M, Spahis S, et al. Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: a randomized, double-blind, placebo-controlled study. Paediatr Child Health. 2009;14(2):89–98. doi:10.1093/pch/14.2.8919436468
   PubMed Web of Science ®Google Scholar
• Salem NJR, Litman B, Kim HY, Gawrisch K. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids. 2001;36(9):945–959. doi:10.1007/s11745-001-0805-611724467
   PubMed Web of Science ®Google Scholar
• Bazan NG, Musto AE, Knott EJ. Endogenous signaling by omega-3 docosahexaenoic acid-derived mediators sustains homeostatic synaptic and circuitry integrity. Mol Neurobiol. 2011;44(2):216–222. doi:10.1007/s12035-011-8200-621918832
   PubMed Web of Science ®Google Scholar
• Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Cin Nutr. 2006;86(6):1467S–1476S. doi:10.1093/ajcn/83.6.1467S
   Web of Science ®Google Scholar
• Wechsler D. The Wechsler Intelligence Scale for Children. 4th ed. London: Pearson Assessment; 2005.
   Google Scholar
• Gasso F, Bogdanov P, Domingo JC. Docosahexaenoic acid improves endogenous antioxidant defense in ARPE-19 cells. Invest Ophthalmol Vis Sci. 2008;49:5932. doi:10.1167/iovs.07-0624
   Web of Science ®Google Scholar
• Results shown in the European Patent EP 1 962 825 B1 (held by BRUDY TECHNOLOGY SL) related to the use of DHA for treating a pathology associated with cellular oxidative damage. European patent granted.2014 4 2.
   Google Scholar
• Brickenkamp R, Zillmer E. The D2 Test of Attention. Seattle, Washington: Hogrefe & Huber Publishers; 1998.
   Google Scholar
• Seisdedos N. D2, Test de Atención. Adaptación española. Madrid: TEA Ediciones; 2002.
   Google Scholar
• Climent G, Banterla F, Iriarte Y. AULA: Theoretical Manual. San Sebastián, Spain: Nesplora; 2011.
   Google Scholar
• Areces D, Rodríguez C, García T, Cueli M, González-Castro P. Efficacy of a continuous performance test on virtual reality in the diagnosis of ADHD and its clinical presentations. J Atten Disord. 2016;22(11):1081–1091. doi:10.1177/108705471662971126896148
   PubMed Web of Science ®Google Scholar
• Rodríguez C, García T, Areces D. New and future challenges concerning the use of virtual reality tools for assessing ADHD. Curr Dev Disord Res. 2017;4:8–10. doi:10.1007/s40474-017-0103-4
   Google Scholar
• Farré A, Narbona J. EDAH:Scale for the Assessment of Attention Deficit Hyperactivity Disorder. Madrid: TEA Ediciones; 2001.
   Google Scholar
• Parker JDA, Sitarenios G, Conners CK. Abbreviated Conner’s rating scales revisited: a confirmatory factor analytic study. J Atten Disord. 1996;1(1):55–62. doi:10.1177/108705479600100105
   Google Scholar
• Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res. 1986;27(1):114–120.3958609
   PubMed Web of Science ®Google Scholar
• Kline RB. Principles and Practice of Structural Equation Modeling. New York (NY): Guilford Press; 2011.
   Google Scholar
• Youdim KA, Martin A, Joseph JA. Essential fatty acids and the brain: possible health implications. Int J Dev Neurosci. 2000;18(4–5):383–399. doi:10.1016/S0736-5748(00)00013-710817922
   PubMed Web of Science ®Google Scholar
• Akbar M, Calderon F, Wen Z, Kim HY. Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Proc Natl Acad Sci U S A. 2005;102(36):1058–1063. doi:10.1073/pnas.0502903102
   Web of Science ®Google Scholar
• Cederholm T, Salem NJR, Palmblad J. ω-3 Fatty acids in the prevention of cognitive decline in humans. Adv Nutr. 2013;4(6):672–676. doi:10.3945/an.113.00455624228198
   PubMed Web of Science ®Google Scholar
• Lauritzen L, Brambilla P, Mazzocchi A, Harsløf LB, Ciappolino V, Agostoni C. DHA effects in brain development and function. Nutrients. 2016;8(1):e6. doi:10.3390/nu801000626742060
   PubMed Web of Science ®Google Scholar
• Bos DJ, Oranje B, Veerhoek ES, et al. Reduced symptoms of inattention after dietary omega-3 fatty acid supplementation in boys with and without attention deficit/hyperactivity disorder. Neuropsychopharmacology. 2015;40(10):2298–2306. doi:10.1038/npp.2015.7325790022
   PubMed Web of Science ®Google Scholar
• Crippa A, Tese A, Sangiorgio F, et al. Behavioral and cognitive effects of docosahexaenoico acid in drug-naïve children with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled clinical trial. Eur Child Adolesc Psychiatry. 2019;28(4):571–583. doi:10.1007/s00787-018-1223-z30246216
   PubMed Web of Science ®Google Scholar
• López-Vicente M, Ribas Fitó N, Vilor-Tejedor N, et al. Prenatal omega-6: omega-3ratio and attention deficit and hyperactivity disorder symptoms. J Pediatr. 2019;22:pii: S0022-3476(19)30246-X. doi:10.1016/j.jpeds.2019.02.022
   Web of Science ®Google Scholar